The application of NLRP3 inflammasome inhibitors or RNA knockdown technology (siRNA-NLRP3) in cognitive impairment models can restore the expression of inflammasomes to normal and significantly improve cognitive function [15–17]. Here, NLRP3 is linked to Cognitive impairment.